Halberd Tax Rate
The Effective Tax Rate of Halberd (HALB) as of Oct 12, 2026 is 36.75 %. In the previous year, Effective Tax Rate was 14.03 % — a change of 161.98% (higher).
Get this data via API
Financial Data API
Tax Rate
36.75 %
YoY
161.98%
Last updated:
Effective Tax Rate of Halberd is 2023 36.75 % . Effective Tax Rate of Halberd was 2022 14.03 % . It decreases by 161.98% higher compared to the previous year.
The Halberd Tax Rate history
3 Years
10 Years
25 Years
Max
Tax Rate
Date
Tax Rate
Jan 1, 2016
82.48 USD
Jan 1, 2017
-7.32 USD
Jan 1, 2018
1,132.56 USD
Jan 1, 2019
784.10 USD
Jan 1, 2020
0.10 USD
Jan 1, 2021
0.11 USD
Jan 1, 2022
14.03 USD
Jan 1, 2023
36.75 USD
| YEAR | Tax Rate | YoY |
|---|---|---|
| 36.75 % | +161.98% | |
| 14.03 % | +12,756.78% | |
| 0.11 % | +8.58% | |
| 0.10 % | -99.99% | |
| 784.10 % | -30.77% | |
| 1,132.56 % | -15,568.89% | |
| -7.32 % | -108.88% | |
| 82.48 % | — |
Access this data via the Eulerpool API
Halberd Stock analysis
What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide.
A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics.
Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities.
Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits.
In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector.
Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Halberd stock
Effective Tax Rate of Halberd is 36.75 % in 2023.
Effective Tax Rate of Halberd changed from 14.03 % to 36.75 %, representing a 161.98% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Effective Tax Rate Halberd since 2006 – with annual values, charts, and detailed analysis.
The effective tax rate measures the actual percentage of pretax income paid in taxes. It reflects the company's tax efficiency and planning.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Effective Tax Rate's Halberd with sector peers and the industry average to assess whether it is attractive.
To evaluate Effective Tax Rate's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Effective Tax Rate.
Access this data via the Eulerpool API
Margins — Halberd
All Key Metrics — Halberd
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth